meglumine has been researched along with Ankylosing Spondylarthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Del Giudice, P; Dereure, J; Hakimi, S; Le Quellec, A; Rivière, S | 1 |
| Deng, M; Griffith, JF; Lee, KK; Lee, VW; Li, EK; Li, TK; Tam, LS; Wang, YX | 1 |
2 other study(ies) available for meglumine and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
Topics: Antibodies, Monoclonal; Antiprotozoal Agents; Antirheumatic Agents; Humans; Infliximab; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2010 |
Vertebral body corner oedema vs gadolinium enhancement as biomarkers of active spinal inflammation in ankylosing spondylitis.
Topics: Adult; Biomarkers; Contrast Media; Edema; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myelitis; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Spine; Spondylitis, Ankylosing; Whole Body Imaging | 2012 |